Herman, T S <br/><br/>
Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.  [electronic resource] 

 -  Cancer research  May 1988 
 - 2693-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Survival--drug effects<br/>Cisplatin--therapeutic use<br/>Combined Modality Therapy<br/>Fibrosarcoma--pathology<br/>Hyperthermia, Induced<br/>Male<br/>Mice<br/>Mice, Inbred C3H